Addressing the utility of a novel score for “At-Risk” MASH in those with significant obesity

Research output: Contribution to journal › Editorial › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Author Accepted Manuscript
Accepted author manuscript, 226 KB
Embargo ends: 08/12/2026 00:00 GMT

@article{8fd35987d32544b68d7ccf942f0c7dc0,

title = "Addressing the utility of a novel score for {\textquotedblleft}At-Risk{\textquotedblright} MASH in those with significant obesity",

keywords = "Non-Invasive Tests, Magnetic Resonance, Fibrosis, At-risk, steatohepatitis",

author = "Dillon, \{John F\} and Damien Leith and Paul Brennan",

note = "Copyright {\textcopyright} 2025 American Association for the Study of Liver Diseases.",

year = "2025",

month = dec,

day = "8",

doi = "10.1097/HEP.0000000000001640",

language = "English",

journal = "Hepatology",

issn = "0270-9139",

publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Addressing the utility of a novel score for “At-Risk” MASH in those with significant obesity

AU - Dillon, John F

AU - Leith, Damien

AU - Brennan, Paul

PY - 2025/12/8

Y1 - 2025/12/8

KW - Non-Invasive Tests

KW - Magnetic Resonance

KW - Fibrosis

KW - At-risk

KW - steatohepatitis

U2 - 10.1097/HEP.0000000000001640

DO - 10.1097/HEP.0000000000001640

M3 - Editorial

C2 - 41359397

SN - 0270-9139

JO - Hepatology

JF - Hepatology

ER -